It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: CanadianMason
a reply to: eisegesis
This --->
What 'off-market' drugs are being provided to [RBG] in order to sustain minimum daily function?
When my wife had cancer several year ago, she could afford an 'off-market' drug that cured her. Such a thing does exist. Her doctor called it the rich man's drug.
Q isn't reaching/stretching on that at all.
Past statement was directed @ confirmation statements, not assumptions (+JA throw in).
These are spread to discredit knowing will not materialize.
Good decoding.
Technically US 11th = SING 12th, correct?
What else might (23) refer to?
Dash v Minus?
Military.
Q
She has had cancer twice, and has attributed her survival partly to the medical care she received at the National Institutes of Health.
“Ever since my colorectal cancer in 1999, I have been followed by the N.I.H.,” she said in a 2013 interview. “That was very lucky for me because they detected my pancreatic cancer at a very early stage” in 2009.
originally posted by: EndtheMadnessNow
a reply to: CanadianMason
She has had cancer twice, and has attributed her survival partly to the medical care she received at the National Institutes of Health.
“Ever since my colorectal cancer in 1999, I have been followed by the N.I.H.,” she said in a 2013 interview. “That was very lucky for me because they detected my pancreatic cancer at a very early stage” in 2009.
www.nytimes.com...
How many people do you know that survived pancreatic cancer? After 10 yrs??
I believe quite rare, no?
Source - pancreatic.org...
According to the American Cancer Society, for all stages of pancreatic cancer combined, the one-year relative survival rate is 20%, and the five-year rate is 7%.
originally posted by: carewemust
there sure seems to be a lot of flights going there. And two invitations to the media for January alone. A lot of activity for the scant 40 prisoners who've been held for many years.
originally posted by: MountainLaurel
Hello, [AS].
Once an agent, always an agent.
Q
It doesn't look the same when you copy and paste this Q post as it does on Q's page, but the ll in Hello is in bold print and it also looks like little dots ( looks like 3 dots, but my eyes aren't great ) under the A in [AS] ? ll = Loretta Lynch ?
(IRAN DEAL - PARIS ACCORD - CHINA TRADE - SYRIA - ………………….)
POWER TO DECLAS CRUCIAL DOCS TO PROVIDE THE PUBLIC W/ THE TRUTH (TRANSPARENCY).
POWER TO GIVE BACK POWER TO THE PEOPLE (AS INTENDED BY OUR FOUNDERS).
LEADER OF THE FREE WORLD.
…………………
Q
originally posted by: FlyingFox
originally posted by: carewemust
there sure seems to be a lot of flights going there. And two invitations to the media for January alone. A lot of activity for the scant 40 prisoners who've been held for many years.
I'm sure they can hear the jet engines and notice the increased traffick.
Swiss pharmaceuticals group Novartis has said it will charge $475,000 (CHF458,000) a patient for its new cancer therapy, putting it among the most expensive drugs of all time.
Cyramza, $13,256 monthly cost per patient
The lung cancer indication is the biggest of the three markets that Cyramza is approved to treat. According to the National Cancer Institute, 224,210 Americans are diagnosed with lung cancer every year, and the vast majority of these are non-small cell lung cancer.
Zykadia, $13,672 monthly cost per patient
Last April, Novartis AG got the FDA to green light Zykadia four months ahead of schedule as a treatment for a very specific type of late-stage non-small cell lung cancer known as ALK-positive NSCLC.
Drugs designed to trigger a patient's immune system may help boost survival for those battling lung cancer, two new studies found.
The first study found that when the immunotherapy drug Keytruda (pembrolizumab) was combined with standard chemotherapy, the chance that a patient would die within the next 11 months plummeted by more than 50 percent, compared with being treated with chemo alone.
In a similar vein, another team of researchers gave patients diagnosed with advanced lung cancer either a combination of the immunotherapy drugs Opdivo (nivolumab) and Yervoy (ipilimumab), or standard chemotherapy. Those on the two immunotherapy drugs were 42 percent less likely to see their disease progress after a year.
The following list (contained in link below), represents the top 20 prescription drugs for the treatment of cancer, in order by sales revenue, for the year 2017.